Skip to main content
Top
Published in: Virology Journal 1/2010

Open Access 01-12-2010 | Research

Use of a highly sensitive strand-specific quantitative PCR to identify abortive replication in the mouse model of respiratory syncytial virus disease

Authors: Richard Bannister, Deborah Rodrigues, Edward J Murray, Carl Laxton, Mike Westby, Helen Bright

Published in: Virology Journal | Issue 1/2010

Login to get access

Abstract

Background

The BALB/c mouse is commonly used to study RSV infection and disease. However, despite the many advantages of this well-characterised model, the inoculum is large, viral replication is restricted and only a very small amount of virus can be recovered from infected animals. A key question in this model is the fate of the administered virus. Is replication really being measured or is the model measuring the survival of the virus over time? To answer these questions we developed a highly sensitive strand-specific quantitative PCR (QPCR) able to accurately quantify the amount of RSV replication in the BALB/c mouse lung, allowing characterisation of RSV negative and positive strand RNA dynamics.

Results

In the mouse lung, no increase in RSV genome was seen above the background of the original inoculum whilst only a limited transient increase (< 1 log) in positive strand, replicative intermediate (RI) RNA occurred. This RNA did however persist at detectable levels for 59 days post infection. As expected, ribavirin therapy reduced levels of infectious virus and RI RNA in the mouse lung. However, whilst Palivizumab therapy was also able to reduce levels of infectious virus, it failed to prevent production of intracellular RI RNA. A comparison of RSV RNA kinetics in human (A549) and mouse (KLN205) cell lines demonstrated that RSV replication was also severely delayed and impaired in vitro in the mouse cells.

Conclusions

This is the first time that such a sensitive strand-specific QPCR technique has been to the RSV mouse system. We have accurately quantified the restricted and abortive nature of RSV replication in the mouse. Further in vitro studies in human and mouse cells suggest this restricted replication is due at least in part to species-specific host cell-viral interactions.
Appendix
Available only for authorised users
Literature
1.
go back to reference Han LL, Alexander JP, Anderson LJ: Respiratory syncytial virus pneumonia among the elderly: an assessment of disease burden. J Infect Dis 1999, 179: 25-30. 10.1086/314567PubMedCrossRef Han LL, Alexander JP, Anderson LJ: Respiratory syncytial virus pneumonia among the elderly: an assessment of disease burden. J Infect Dis 1999, 179: 25-30. 10.1086/314567PubMedCrossRef
2.
go back to reference McCarthy AJ, Kingman HM, Kelly C, Taylor GS, Caul EO, Grier D, Moppett J, Foot AB, Cornish JM, Oakhill A, et al.: The outcome of 26 patients with respiratory syncytial virus infection following allogeneic stem cell transplantation. Bone Marrow Transplant 1999, 24: 1315-1322. 10.1038/sj.bmt.1702078PubMedCrossRef McCarthy AJ, Kingman HM, Kelly C, Taylor GS, Caul EO, Grier D, Moppett J, Foot AB, Cornish JM, Oakhill A, et al.: The outcome of 26 patients with respiratory syncytial virus infection following allogeneic stem cell transplantation. Bone Marrow Transplant 1999, 24: 1315-1322. 10.1038/sj.bmt.1702078PubMedCrossRef
3.
go back to reference Glezen WP, Greenberg SB, Atmar RL, Piedra PA, Couch RB: Impact of respiratory virus infections on persons with chronic underlying conditions. Jama 2000, 283: 499-505. 10.1001/jama.283.4.499PubMedCrossRef Glezen WP, Greenberg SB, Atmar RL, Piedra PA, Couch RB: Impact of respiratory virus infections on persons with chronic underlying conditions. Jama 2000, 283: 499-505. 10.1001/jama.283.4.499PubMedCrossRef
4.
go back to reference Leader S, Kohlhase K: Recent trends in severe respiratory syncytial virus (RSV) among US infants, 1997 to 2000. J Pediatr 2003, 143: S127-132.PubMedCrossRef Leader S, Kohlhase K: Recent trends in severe respiratory syncytial virus (RSV) among US infants, 1997 to 2000. J Pediatr 2003, 143: S127-132.PubMedCrossRef
5.
go back to reference DeVincenzo JP: Therapy of respiratory syncytial virus infection. Pediatr Infect Dis J 2000, 19: 786-790. discussion 802-784, 811-783PubMedCrossRef DeVincenzo JP: Therapy of respiratory syncytial virus infection. Pediatr Infect Dis J 2000, 19: 786-790. discussion 802-784, 811-783PubMedCrossRef
6.
go back to reference Greenough A, Thomas M: Respiratory syncytial virus prevention: past and present strategies. Expert Opin Pharmacother 2000, 1: 1195-1201. 10.1517/14656566.1.6.1195PubMedCrossRef Greenough A, Thomas M: Respiratory syncytial virus prevention: past and present strategies. Expert Opin Pharmacother 2000, 1: 1195-1201. 10.1517/14656566.1.6.1195PubMedCrossRef
7.
go back to reference Saez-Llorens X, Moreno MT, Ramilo O, Sanchez PJ, Top FH Jr, Connor EM: Safety and pharmacokinetics of palivizumab therapy in children hospitalized with respiratory syncytial virus infection. Pediatr Infect Dis J 2004, 23: 707-712. 10.1097/01.inf.0000133165.85909.08PubMedCrossRef Saez-Llorens X, Moreno MT, Ramilo O, Sanchez PJ, Top FH Jr, Connor EM: Safety and pharmacokinetics of palivizumab therapy in children hospitalized with respiratory syncytial virus infection. Pediatr Infect Dis J 2004, 23: 707-712. 10.1097/01.inf.0000133165.85909.08PubMedCrossRef
8.
go back to reference Andries K, Moeremans M, Gevers T, Willebrords R, Sommen C, Lacrampe J, Janssens F, Wyde PR: Substituted benzimidazoles with nanomolar activity against respiratory syncytial virus. Antiviral Res 2003, 60: 209-219. 10.1016/j.antiviral.2003.07.004PubMedCrossRef Andries K, Moeremans M, Gevers T, Willebrords R, Sommen C, Lacrampe J, Janssens F, Wyde PR: Substituted benzimidazoles with nanomolar activity against respiratory syncytial virus. Antiviral Res 2003, 60: 209-219. 10.1016/j.antiviral.2003.07.004PubMedCrossRef
9.
go back to reference Douglas JL, Panis ML, Ho E, Lin KY, Krawczyk SH, Grant DM, Cai R, Swaminathan S, Cihlar T: Inhibition of respiratory syncytial virus fusion by the small molecule VP-14637 via specific interactions with F protein. J Virol 2003, 77: 5054-5064. 10.1128/JVI.77.9.5054-5064.2003PubMedPubMedCentralCrossRef Douglas JL, Panis ML, Ho E, Lin KY, Krawczyk SH, Grant DM, Cai R, Swaminathan S, Cihlar T: Inhibition of respiratory syncytial virus fusion by the small molecule VP-14637 via specific interactions with F protein. J Virol 2003, 77: 5054-5064. 10.1128/JVI.77.9.5054-5064.2003PubMedPubMedCentralCrossRef
10.
go back to reference Wyde PR, Chetty SN, Timmerman P, Gilbert BE, Andries K: Short duration aerosols of JNJ 2408068 (R170591) administered prophylactically or therapeutically protect cotton rats from experimental respiratory syncytial virus infection. Antiviral Res 2003, 60: 221-231. 10.1016/j.antiviral.2003.07.002PubMedCrossRef Wyde PR, Chetty SN, Timmerman P, Gilbert BE, Andries K: Short duration aerosols of JNJ 2408068 (R170591) administered prophylactically or therapeutically protect cotton rats from experimental respiratory syncytial virus infection. Antiviral Res 2003, 60: 221-231. 10.1016/j.antiviral.2003.07.002PubMedCrossRef
11.
go back to reference Cowton VM, McGivern DR, Fearns R: Unravelling the complexities of respiratory syncytial virus RNA synthesis. J Gen Virol 2006, 87: 1805-1821. 10.1099/vir.0.81786-0PubMedCrossRef Cowton VM, McGivern DR, Fearns R: Unravelling the complexities of respiratory syncytial virus RNA synthesis. J Gen Virol 2006, 87: 1805-1821. 10.1099/vir.0.81786-0PubMedCrossRef
12.
go back to reference Hacking D, Hull J: Respiratory syncytial virus--viral biology and the host response. J Infect 2002, 45: 18-24. 10.1053/jinf.2002.1015PubMedCrossRef Hacking D, Hull J: Respiratory syncytial virus--viral biology and the host response. J Infect 2002, 45: 18-24. 10.1053/jinf.2002.1015PubMedCrossRef
13.
go back to reference Sugrue RJ: Interactions between respiratory syncytial virus and the host cell: opportunities for antivirus strategies? Expert Rev Mol Med 2006, 8: 1-17. 10.1017/S1462399406000081PubMedCrossRef Sugrue RJ: Interactions between respiratory syncytial virus and the host cell: opportunities for antivirus strategies? Expert Rev Mol Med 2006, 8: 1-17. 10.1017/S1462399406000081PubMedCrossRef
14.
go back to reference Domachowske JB, Bonville CA, Rosenberg HF: Animal models for studying respiratory syncytial virus infection and its long term effects on lung function. Pediatr Infect Dis J 2004, 23: S228-234. 10.1097/01.inf.0000144672.81955.a4PubMedCrossRef Domachowske JB, Bonville CA, Rosenberg HF: Animal models for studying respiratory syncytial virus infection and its long term effects on lung function. Pediatr Infect Dis J 2004, 23: S228-234. 10.1097/01.inf.0000144672.81955.a4PubMedCrossRef
15.
go back to reference Estripeaut D, Torres JP, Somers CS, Tagliabue C, Khokhar S, Bhoj VG, Grube SM, Wozniakowski A, Gomez AM, Ramilo O, et al.: Respiratory syncytial virus persistence in the lungs correlates with airway hyperreactivity in the mouse model. J Infect Dis 2008, 198: 1435-1443. 10.1086/592714PubMedPubMedCentralCrossRef Estripeaut D, Torres JP, Somers CS, Tagliabue C, Khokhar S, Bhoj VG, Grube SM, Wozniakowski A, Gomez AM, Ramilo O, et al.: Respiratory syncytial virus persistence in the lungs correlates with airway hyperreactivity in the mouse model. J Infect Dis 2008, 198: 1435-1443. 10.1086/592714PubMedPubMedCentralCrossRef
16.
go back to reference Boukhvalova MS, Prince GA, Blanco JC: Respiratory syncytial virus infects and abortively replicates in the lungs in spite of preexisting immunity. J Virol 2007, 81: 9443-9450. 10.1128/JVI.00102-07PubMedPubMedCentralCrossRef Boukhvalova MS, Prince GA, Blanco JC: Respiratory syncytial virus infects and abortively replicates in the lungs in spite of preexisting immunity. J Virol 2007, 81: 9443-9450. 10.1128/JVI.00102-07PubMedPubMedCentralCrossRef
17.
go back to reference Boukhvalova MS, Prince GA, Blanco JC: The cotton rat model of respiratory viral infections. Biologicals 2009, 37: 152-159. 10.1016/j.biologicals.2009.02.017PubMedPubMedCentralCrossRef Boukhvalova MS, Prince GA, Blanco JC: The cotton rat model of respiratory viral infections. Biologicals 2009, 37: 152-159. 10.1016/j.biologicals.2009.02.017PubMedPubMedCentralCrossRef
18.
go back to reference Taylor G, Stott EJ, Hughes M, Collins AP: Respiratory syncytial virus infection in mice. Infect Immun 1984, 43: 649-655.PubMedPubMedCentral Taylor G, Stott EJ, Hughes M, Collins AP: Respiratory syncytial virus infection in mice. Infect Immun 1984, 43: 649-655.PubMedPubMedCentral
19.
go back to reference Vaux-Peretz F, Meignier B: Comparison of lung histopathology and bronchoalveolar lavage cytology in mice and cotton rats infected with respiratory syncytial virus. Vaccine 1990, 8: 543-548. 10.1016/0264-410X(90)90005-7PubMedCrossRef Vaux-Peretz F, Meignier B: Comparison of lung histopathology and bronchoalveolar lavage cytology in mice and cotton rats infected with respiratory syncytial virus. Vaccine 1990, 8: 543-548. 10.1016/0264-410X(90)90005-7PubMedCrossRef
20.
go back to reference Malhotra R, Ward M, Bright H, Priest R, Foster MR, Hurle M, Blair E, Bird M: Isolation and characterisation of potential respiratory syncytial virus receptor(s) on epithelial cells. Microbes Infect 2003, 5: 123-133. 10.1016/S1286-4579(02)00079-5PubMedCrossRef Malhotra R, Ward M, Bright H, Priest R, Foster MR, Hurle M, Blair E, Bird M: Isolation and characterisation of potential respiratory syncytial virus receptor(s) on epithelial cells. Microbes Infect 2003, 5: 123-133. 10.1016/S1286-4579(02)00079-5PubMedCrossRef
21.
go back to reference Bessaud M, Autret A, Jegouic S, Balanant J, Joffret ML, Delpeyroux F: Development of a Taqman RT-PCR assay for the detection and quantification of negatively stranded RNA of human enteroviruses: evidence for false-priming and improvement by tagged RT-PCR. J Virol Methods 2008, 153: 182-189. 10.1016/j.jviromet.2008.07.010PubMedCrossRef Bessaud M, Autret A, Jegouic S, Balanant J, Joffret ML, Delpeyroux F: Development of a Taqman RT-PCR assay for the detection and quantification of negatively stranded RNA of human enteroviruses: evidence for false-priming and improvement by tagged RT-PCR. J Virol Methods 2008, 153: 182-189. 10.1016/j.jviromet.2008.07.010PubMedCrossRef
22.
go back to reference Chavez-Bueno S, Mejias A, Gomez AM, Olsen KD, Rios AM, Fonseca-Aten M, Ramilo O, Jafri HS: Respiratory syncytial virus-induced acute and chronic airway disease is independent of genetic background: an experimental murine model. Virol J 2005, 2: 46. 10.1186/1743-422X-2-46PubMedPubMedCentralCrossRef Chavez-Bueno S, Mejias A, Gomez AM, Olsen KD, Rios AM, Fonseca-Aten M, Ramilo O, Jafri HS: Respiratory syncytial virus-induced acute and chronic airway disease is independent of genetic background: an experimental murine model. Virol J 2005, 2: 46. 10.1186/1743-422X-2-46PubMedPubMedCentralCrossRef
23.
go back to reference Schwarze J, O'Donnell DR, Rohwedder A, Openshaw PJ: Latency and persistence of respiratory syncytial virus despite T cell immunity. Am J Respir Crit Care Med 2004, 169: 801-805. 10.1164/rccm.200308-1203OCPubMedCrossRef Schwarze J, O'Donnell DR, Rohwedder A, Openshaw PJ: Latency and persistence of respiratory syncytial virus despite T cell immunity. Am J Respir Crit Care Med 2004, 169: 801-805. 10.1164/rccm.200308-1203OCPubMedCrossRef
24.
go back to reference Wilkinson TM, Donaldson GC, Johnston SL, Openshaw PJ, Wedzicha JA: Respiratory syncytial virus, airway inflammation, and FEV1 decline in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2006, 173: 871-876. 10.1164/rccm.200509-1489OCPubMedCrossRef Wilkinson TM, Donaldson GC, Johnston SL, Openshaw PJ, Wedzicha JA: Respiratory syncytial virus, airway inflammation, and FEV1 decline in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2006, 173: 871-876. 10.1164/rccm.200509-1489OCPubMedCrossRef
25.
go back to reference Falsey AR, Formica MA, Hennessey PA, Criddle MM, Sullender WM, Walsh EE: Detection of respiratory syncytial virus in adults with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2006, 173: 639-643. 10.1164/rccm.200510-1681OCPubMedPubMedCentralCrossRef Falsey AR, Formica MA, Hennessey PA, Criddle MM, Sullender WM, Walsh EE: Detection of respiratory syncytial virus in adults with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2006, 173: 639-643. 10.1164/rccm.200510-1681OCPubMedPubMedCentralCrossRef
26.
go back to reference Sikkel MB, Quint JK, Mallia P, Wedzicha JA, Johnston SL: Respiratory syncytial virus persistence in chronic obstructive pulmonary disease. Pediatr Infect Dis J 2008, 27: S63-70. 10.1097/INF.0b013e3181684d67PubMedCrossRef Sikkel MB, Quint JK, Mallia P, Wedzicha JA, Johnston SL: Respiratory syncytial virus persistence in chronic obstructive pulmonary disease. Pediatr Infect Dis J 2008, 27: S63-70. 10.1097/INF.0b013e3181684d67PubMedCrossRef
27.
go back to reference Sidwell RW, Barnard DL: Respiratory syncytial virus infections: recent prospects for control. Antiviral Res 2006, 71: 379-390. 10.1016/j.antiviral.2006.05.014PubMedCrossRef Sidwell RW, Barnard DL: Respiratory syncytial virus infections: recent prospects for control. Antiviral Res 2006, 71: 379-390. 10.1016/j.antiviral.2006.05.014PubMedCrossRef
28.
go back to reference Elliott J, Lynch OT, Suessmuth Y, Qian P, Boyd CR, Burrows JF, Buick R, Stevenson NJ, Touzelet O, Gadina M, et al.: Respiratory syncytial virus NS1 protein degrades STAT2 by using the Elongin-Cullin E3 ligase. J Virol 2007, 81: 3428-3436. 10.1128/JVI.02303-06PubMedPubMedCentralCrossRef Elliott J, Lynch OT, Suessmuth Y, Qian P, Boyd CR, Burrows JF, Buick R, Stevenson NJ, Touzelet O, Gadina M, et al.: Respiratory syncytial virus NS1 protein degrades STAT2 by using the Elongin-Cullin E3 ligase. J Virol 2007, 81: 3428-3436. 10.1128/JVI.02303-06PubMedPubMedCentralCrossRef
29.
go back to reference Hanada N, Morishima T, Nishikawa K, Isomura S, Nagai Y: Interferon-mediated self-limiting growth of respiratory syncytial virus in mouse embryo cells. J Med Virol 1986, 20: 363-370. 10.1002/jmv.1890200409PubMedCrossRef Hanada N, Morishima T, Nishikawa K, Isomura S, Nagai Y: Interferon-mediated self-limiting growth of respiratory syncytial virus in mouse embryo cells. J Med Virol 1986, 20: 363-370. 10.1002/jmv.1890200409PubMedCrossRef
30.
go back to reference Dupuy LC, Dobson S, Bitko V, Barik S: Casein kinase 2-mediated phosphorylation of respiratory syncytial virus phosphoprotein P is essential for the transcription elongation activity of the viral polymerase; phosphorylation by casein kinase 1 occurs mainly at Ser(215) and is without effect. J Virol 1999, 73: 8384-8392.PubMedPubMedCentral Dupuy LC, Dobson S, Bitko V, Barik S: Casein kinase 2-mediated phosphorylation of respiratory syncytial virus phosphoprotein P is essential for the transcription elongation activity of the viral polymerase; phosphorylation by casein kinase 1 occurs mainly at Ser(215) and is without effect. J Virol 1999, 73: 8384-8392.PubMedPubMedCentral
Metadata
Title
Use of a highly sensitive strand-specific quantitative PCR to identify abortive replication in the mouse model of respiratory syncytial virus disease
Authors
Richard Bannister
Deborah Rodrigues
Edward J Murray
Carl Laxton
Mike Westby
Helen Bright
Publication date
01-12-2010
Publisher
BioMed Central
Published in
Virology Journal / Issue 1/2010
Electronic ISSN: 1743-422X
DOI
https://doi.org/10.1186/1743-422X-7-250

Other articles of this Issue 1/2010

Virology Journal 1/2010 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.